This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Options Recap: Bullish on Netflix, Visa

OptionMonster co-founder Pete Najarian provides options picks Monday, Wednesday and Friday in TheStreet.com's Deep in the Money Calls newsletter.

David Russell, reporter for OptionMonster.

Trading turns bullish on Netflix (NFLX - Get Report): Stock and options trading turn bullish on the movie-rental company as investors position for NFLX to rally this week.

Options bet on comeback for Sepracor (SEPR): The biotechnology company gapped lower early this month, and at least one trader is betting on a rebound for the firm.

Trader stays bullish on Brazil stocks: One large investor is apparently still bullish on Brazil and used options to roll forward a protective position on the iShares MSCI Brazil Index Fund (EWZ).

Losing trades should be analyzed: Traders are usually willing to tell you all about their big winners, but it is often more instructive to look at the losers.

Bull bets on Visa (V - Get Report): At least one big investor, bullish on Visa ahead of the next earnings release, is selling puts and buying calls.

Monday Pre-Market:

Movies and the malls: Jon Najarian says his money's on teen and 'tween retailers getting the most "Transformational" business from this summer's blockbusters.

Options point to quick move for Mosaic (MOS - Get Report): Trading turned bullish on the fertilizer company Friday, with most investors expecting a quick rally in the shares.

Indexes remain in bearish patterns: With the bulk of earnings reports in the next two weeks from the big players, the situation is bound to change. For now, the indexes remain in the bearish price patterns noted earlier.

Options surge on FDA ruling for Eli Lilly (LLY - Get Report): Stock and options trading took a bullish turn in the pharmaceuticals company late Friday after the Food and Drug Administration approved the company's Effient blood-thinning drug.

Bulls look for breakout at Allergan (AGN): Botox maker Allergan has been drifting sideways for more than three months, and now some traders are looking for a move higher.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
EWZ $36.32 -0.74%
AGN $240.22 1.21%
LLY $71.95 0.06%
NFLX $558.34 -1.30%
MOS $44.43 0.73%

Markets

DOW 17,819.80 -108.40 -0.60%
S&P 500 2,079.94 -9.52 -0.46%
NASDAQ 4,918.4020 -20.9250 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs